Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

GMAB

GENMAB A/S

CIK 0001434265 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$33.45
↑ 0.04 (0.12%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Options

Key stats

Market Cap
$20.86B
P/E Ratio
21.66
EPS
15.50
Dividend Yield
Not covered
52W Position
83%
Beta
0.77

Valuation multiples

Fwd P/E
19.61
PEG
5.66
P/B
3.57
P/S
5.61
EV/Revenue
6.49
ROE
16.5%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 83%
$23.62$35.43

Latest Financials

2025-12-31 FY
Revenue
$3.72B
Net Income
$963.00M
Total Assets
$12.87B
Free Cash Flow
$1.15B

Recent news